Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Fabry Disease Treatment Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for messenger RNA as a treatment modality for Fabry disease
5.1.1.2. Increasing number of clinical trials
5.1.1.3. Growing incidences of genetic disorders and increasing awareness
5.1.2. Restraints
5.1.2.1. Lack of awareness about advancements with respect to treatments for Fabry disease
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for the treatment of Fabry disease
5.1.3.2. Increasing healthcare expenditure and improving infrastructure in emerging economies
5.1.4. Challenges
5.1.4.1. Limitations in adopting new technologies in certain countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Fabry Disease Treatment Market, by Treatment Type
6.1. Introduction
6.2. Chaperone Treatment
6.3. Enzyme Replacement Therapy
6.4. Organ-Specific Treatment
6.5. Substrate Reduction Therapy

7. Fabry Disease Treatment Market, by Drugs
7.1. Introduction
7.2. Agalsidase Beta
7.3. Migalastat
7.4. Pipeline Drugs

8. Fabry Disease Treatment Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral

9. Americas Fabry Disease Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Fabry Disease Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Fabry Disease Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amicus Therapeutics Inc.
13.1.2. Avrobio Inc.
13.1.3. BioMarin
13.1.4. Biosidus S.A.
13.1.5. Digestive Care, Inc.
13.1.6. GlaxoSmithKline PLC
13.1.7. Idorsia Pharmaceuticals Ltd.
13.1.8. ISU Abxis Co Ltd.
13.1.9. JCR Pharmaceuticals Co Ltd.
13.1.10. Leadiant Biosciences, Inc.
13.1.11. Nestle Health Science
13.1.12. Pfizer Inc.
13.1.13. Protalix Biotherapeutics Inc.
13.1.14. Sanofi S.A.
13.1.15. Takeda Pharmaceutical Company Limited
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. FABRY DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. FABRY DISEASE TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. FABRY DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. FABRY DISEASE TREATMENT MARKET DYNAMICS
FIGURE 7. FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
FIGURE 8. FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2022 VS 2030 (%)
FIGURE 10. FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 12. FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. FABRY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. FABRY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. FABRY DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. FABRY DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 11. FABRY DISEASE TREATMENT MARKET SIZE, BY AGALSIDASE BETA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. FABRY DISEASE TREATMENT MARKET SIZE, BY MIGALASTAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. FABRY DISEASE TREATMENT MARKET SIZE, BY PIPELINE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. FABRY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. FABRY DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 29. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 32. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 46. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 49. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 55. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 73. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 86. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 92. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 95. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 101. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 116. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 137. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FABRY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 145. FABRY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 146. FABRY DISEASE TREATMENT MARKET LICENSE & PRICING